U.S. Integrated Delivery Networks Market
Get a free sample of this report
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Request Sectional Data
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
U.S. Integrated Delivery Networks Market was valued at around USD 22.5 billion in 2023 and is estimated to expand at over 9.1% CAGR from 2024 to 2032. This robust market growth is anticipated to various factors including growing demand for population health management strategies, technological advancements and increasing prevalence of chronic diseases among others.
Additionally, surging need for value-based healthcare services, along with rising demand for accountable care and clinical integration are other variables fueling the market expansion. Moreover, IDNs are well-suited for managing chronic diseases as they provide continuous, coordinated treatment. The ageing population's prevalence of chronic diseases contributes to the demand for integrated and holistic healthcare services.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
U.S. Integrated Delivery Networks Market Size in 2023: | USD 22.5 Billion |
Forecast Period: | 2018 to 2023 |
Forecast Period 2023 - 2032 CAGR: | 9.1 |
2023 Value Projection: | USD 50.6 Billion |
Historical Data for: | 2024 to 2032 |
No of Pages: | 50 |
Tables, Charts & Figures: | 57 |
Segments Covered: | Integration Model, Service Type, Ownership Type, and Component |
Growth Drivers: |
|
Pitfalls Challenges: |
|
For instance, according to the National Center for Chronic Disease Prevention, 6 in 10 individuals in the U.S. are living with chronic diseases such as cancer, heart disease, or diabetes. Chronic diseases are among the most prevalent causes of mortality in the country, accounting for approximately 38% of all fatal accidents. Hence, the aforementioned factors are anticipated to spur the market development.
Integrated Delivery Networks (IDNs) in the U.S. healthcare system refers to organized networks of healthcare providers and facilities that work together to deliver a coordinated and comprehensive range of healthcare services. These networks are designed to improve the efficiency, quality, and accessibility of healthcare services by integrating various components of the healthcare system.
The COVID-19 pandemic had a slightly negative impact on the U.S. integrated delivery networks market. The pandemic underscored the importance of healthcare system resilience and the need for integrated and coordinated care. IDNs played a crucial role in managing the crisis by leveraging their infrastructure for efficient resource allocation, adopting telehealth solutions to ensure continuity of care, and emphasizing population health management to address the unique challenges posed by the virus.
The market is influenced by several factors such as rising demand for integrated telehealth services, surging need for incorporated digital health solutions, and increasing adoption of patient-centric care models that focus on individualized and coordinated care plans, which also influenced the market.
The market by integration model is categorized into vertical, and horizontal. The vertical segment garnered around USD 15.5 billion revenue in 2023.
Based on service type, the U.S. integrated delivery networks market is segmented into acute care, primary care, long-term health, specialty care, and other service types. The acute care segment accounted for over 53% business share in 2023 and is anticipated to witness robust growth during the forecast period.
The U.S. integrated delivery networks market by ownership type is categorized into non-profit IDNs, for-profit IDNs, and government owned IDNs. The non-profit IDNs segment accounted for over USD 15.2 billion revenue size in 2023.
Based on component, the U.S. integrated delivery networks market is bifurcated into hospitals, physician groups, health clinics, ambulatory surgery centers, imaging centers, and post-acute care centers. The hospitals segment dominated the market and accounted for over 44% business share in 2023.
The U.S. integrated delivery networks industry is competitive in nature, with several large, small and mid-sized network companies competing in the industry. Incorporating advanced technologies along with better end-to-end care facilities for patients is among the key focus areas for IDNs. Some of the leading industry IDNs including HCA Healthcare, Ascension, Kaiser Foundation Health Plan, Inc., UNITEDHEALTH GROUP, among others have a notable presence in the market.
Some of the eminent market participants operating in the U.S. integrated delivery networks industry include:
By Integration Model, 2018-2032 (USD Million)
By Service Type, 2018-2032 (USD Million)
By Ownership Type, 2018-2032 (USD Million)
By Component, 2018-2032 (USD Million)
HCA Healthcare, Ascension, Kaiser Foundation Health Plan, Inc., UNITEDHEALTH GROUP, Providence, UPMC HEALTH PLAN, INC., Trinity Health, and TH Medical, are some of the major integrated delivery networks companies in the U.S.
The acute care service type segment held over 53% share of the U.S. integrated delivery networks industry in 2023 owing to their integration in advanced medical technologies, including diagnostic tools, imaging equipment, and surgical innovations.
U.S. integrated delivery networks industry from the vertical integration model segment recorded USD 15.5 billion by 2023 and is expected to register an appreciable CAGR from 2024-2032 owing to the substantial prevalence of chronic diseases in the country.
U.S. integrated delivery networks industry size was USD 22.5 billion in 2023 and is expected to reach over 50.6 billion by 2032 due to the growing demand for population health management strategies, technological advancements and the increasing prevalence of chronic diseases in the region.